Latest News

Friday, April 29, 2016 | Conferences, Bausch+Lomb

Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle

Bausch + Lomb announced that eight scientific posters will address the results of a variety of research studies, which feature several of the company’s current product offerings and pipeline pro…

Read the full story

Friday, April 29, 2016 | Conferences, Medical Studies

Femto Trial Results Awaited From Cataract Surgery Meeting

A prospective randomized trial comparing femtosecond laser-assisted cataract surgery with traditional phacoemulsification for eyes with a shallow anterior chamber will be presented at the upcoming Ame…

Read the full story

Friday, April 29, 2016 | Product Releases

Surgical Specialties to Showcase Growing Family of Sharpoint Ophthalmic Instruments at the Upcoming ASCRS Annual Meeting

Surgical Specialties will showcase its growing family of Sharpoint products, including single use surgical instruments, at the upcoming American Society of Cataract and Refractive Surgeons (ASCR…

Read the full story

Friday, April 29, 2016 | Patents

Google Filed Patent For Injecting A Device Directly Into Your Eye To Improve Vision

Google has a penchant for far-out tech that never reaches the market. The latest is a method of injecting an device into an eyeball, mostly as a means to correct poor vision. Described in a patent dat…

Read the full story

Friday, April 29, 2016 | Conferences, Eleven Biotherapeutics

Eleven Biotherapeutics to Present Data at the ARVO 2016 Annual Meeting

Eleven Biotherapeutics announced that one oral presentation and three posters have been selected for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting…

Read the full story

Friday, April 29, 2016 | Management/Leadership

Ora Appoints David Hollander, MD, MBA, as Chief Medical Officer

Ora announced the appointment of David A. Hollander, MD, MBA, as Chief Medical Officer and Senior Vice-President, according to a company news release. Dr. Hollander most recently served as Therapeutic…

Read the full story

Friday, April 29, 2016 | Medical Studies

Endophthalmitis Rare in Intravitreal Injections

Vigilance and quick treatment can save the vision of most patients who develop endophthalmitis as a rare result of intravitreal injections, researchers say. Vision returned to baseline in eight of 13 …

Read the full story

Thursday, April 28, 2016 | Clinical Trials, Ocular Therapeutix

Ocular Therapeutix Completes End-of-Phase 2 Review with FDA for OTX-TP for Glaucoma and Ocular Hypertension

Ocular Therapeutix announced that it has completed its end-of-phase 2 review with the FDA for its OTX-TP (sustained-release travoprost) product candidate for the treatment of glaucoma and ocular hyper…

Read the full story

Thursday, April 28, 2016 | Clinical Trials, NightstaRx

NightstaRx Reports Long-Term Benefits of Gene Therapy for Inherited Form of Progressive Blindness

NightstaRx announced the publication from the University of Oxford of promising clinical results and long-term benefits of choroideremia gene therapy in this week’s issue of the New England Jour…

Read the full story

Thursday, April 28, 2016 | Health Care, Valeant

Senate Committee Condemns Valeant's Business Model

The Senate Committee on Aging criticized Valeant's business model, with committee members saying that investors played an “outsized role” in the company's decision-making and that …

Read the full story

Thursday, April 28, 2016 | Product Releases

Icare Unveils the ic100 Handheld Tonometer Featuring Several Design Upgrades

Icare USA, a subsidiary of Icare Finland, announced the release of the Icare ic100 tonometer, according to a company news release. The Icare ic100 uses the same rebound technology as its success…

Read the full story

Thursday, April 28, 2016 | Conferences, Clearside Biomedical

Clearside Biomedical to Present Data on Suprachoroidal Drug Administration at 2016 ARVO Meeting

Clearside Biomedical announced four poster presentations associated with suprachoroidal drug administration will be presented at the 2016 Annual Meeting of the Association for Research in Vision and O…

Read the full story

Thursday, April 28, 2016 | Conferences, Glaucoma, Glaukos Corporation

Glaukos Featured in Numerous Presentations at 2016 American Society of Cataract and Refractive Surgery

Glaukos announced that its products will be featured in numerous presentations at the annual American Society of Cataract and Refractive Surgery (ASCRS) meeting being held at the Ernest N. Morial Conv…

Read the full story

Thursday, April 28, 2016 | Management/Leadership, Ophthotech

Carmen A. Puliafito, MD, MBA, Former Dean of Keck School of Medicine of the University of Southern California, Joins Ophthotech as Chief of Strategic Development

Ophthotech announced the appointment of Carmen A. Puliafito, MD, MBA, as Chief of Strategic Development, according to a company news release. As one of the world's leading experts in ophthalmol…

Read the full story

Thursday, April 28, 2016 | Medical Studies

Gene Therapy for Choroideremia Improves Vision After 3.5 Years

An experimental gene therapy continued to improve the vision of some patients with choroideremia at 3.5 years of follow-up in a phase 1/2 clinical trial. In showing efficacy for this length of time, t…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $15.86  0.00% 
 Akorn, Inc. $25.45  0.00% 
 Alimera Sciences, Inc. $2.22  0.00% 
 Allergan $216.56  0.00% 
 Avalanche Biotechnologies $5.64  0.00% 
 Bayer $113.08  0.00% 
 Can-Fite Biopharma $2.84  0.00% 
 Carl Zeiss Meditec $28.49  0.00% 
 Cooper Companies, Inc. $153.08  0.00% 
 Eleven Biotherapeutics $0.87  0.00% 
 Escalon Medical Corp. $0.80  0.00% 
 Essilor International $125.75  0.00% 
 Glaukos $18.84  0.00% 
 Imprimis Pharmaceuticals, Inc. $3.95  0.00% 
 Inotek Pharmaceuticals $9.80  0.00% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $11.45  0.00% 
 Johnson & Johnson $112.08  0.00% 
 Luxottica Group, S.p.A. $54.73  0.00% 
 Merck & Company, Inc. $54.84  0.00% 
 NicOx $8.55  0.00% 
 NovaBay Pharmaceuticals, Inc. $3.16  0.00% 
 Novartis AG Common Stock $75.97  0.00% 
 Ocular Therapeutix $12.28  0.00% 
 Ophthotech Corporation $46.74  0.00% 
 QLT $1.50  0.00% 
 Quantel $3.62  0.00% 
 Regeneron $376.71  0.00% 
 Roche $31.57  0.00% 
 Second Sight Medical Products $4.73  0.00% 
 Shire $187.42  0.00% 
 STAAR Surgical Company $7.71  0.00% 
 TearLab Corporation $0.78  0.00% 
 Thrombogenics $3.70  0.00% 
 Topcon Corporation $12.53  0.00% 
 TriVascular Technologies, Inc. $5.87  0.00% 
 Valeant Pharmaceuticals $33.36  0.00% 
 Xoma $0.82  0.00%